Sana Biotechnology (SANA) Other Operating Expenses (2020 - 2026)

Sana Biotechnology (SANA) has 7 years of Other Operating Expenses data on file, last reported at $8.4 million in Q1 2026.

• For the quarter ending Q1 2026, Other Operating Expenses rose 330.91% year-over-year to $8.4 million; the trailing twelve-month figure through Mar 2026 stood at -$112.1 million (up 25.72% YoY), and the FY2025 full-year result was -$167.0 million, up 36.94% from the prior year.
• Other Operating Expenses improved to $8.4 million in Q1 2026, from -$44.3 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $26.7 million in Q2 2023 to a low of -$249.4 million in Q4 2022.
• A 5-year average of -$54.5 million and a median of -$38.3 million in 2025 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses tumbled 57315.0% in 2024 and soared 330.91% in 2026, its largest moves.
• Tracing SANA's Other Operating Expenses over 5 years: stood at -$249.4 million in 2022, then increased by 15.82% to -$210.0 million in 2023, then soared by 92.11% to -$16.6 million in 2024, then slumped by 167.52% to -$44.3 million in 2025, then jumped by 119.02% to $8.4 million in 2026.
• Business Quant data shows SANA's Other Operating Expenses at $8.4 million in Q1 2026, -$44.3 million in Q4 2025, and -$38.3 million in Q3 2025.